Natural killer cell receptors regulate responses of HLA-E-restricted T cells.

CD8-Positive T-Lymphocytes / immunology Cytomegalovirus / immunology Cytomegalovirus Infections / blood Histocompatibility Antigens Class I / metabolism Humans Killer Cells, Natural / immunology Receptors, Antigen, T-Cell / metabolism Receptors, Natural Killer Cell / metabolism Viral Proteins / immunology HLA-E Antigens

Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
23 04 2021
Historique:
received: 23 09 2020
accepted: 25 03 2021
entrez: 24 4 2021
pubmed: 25 4 2021
medline: 1 3 2022
Statut: ppublish

Résumé

Human cytomegalovirus (CMV) infection can stimulate robust human leukocyte antigen (HLA)-E-restricted CD8

Identifiants

DOI: 10.1126/sciimmunol.abe9057 PMID: 33893172
pubmed: 33893172
pii: 6/58/eabe9057
doi: 10.1126/sciimmunol.abe9057
pii:
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
Receptors, Antigen, T-Cell 0
Receptors, Natural Killer Cell 0
UL40 glycoprotein, Cytomegalovirus 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Lucy C Sullivan (LC)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia. lcsull@unimelb.edu.au agbrooks@unimelb.edu.au.
Lung Transplant Service, The Alfred Hospital and Monash University Melbourne, Victoria 3000, Australia.
ORCID: 0000-0003-2907-4989

Thi H O Nguyen (THO)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.
ORCID: 0000-0002-9294-7693

Christopher M Harpur (CM)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.
ORCID: 0000-0002-3238-9861

Sanda Stankovic (S)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.

Abbie R Kanagarajah (AR)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.

Marios Koutsakos (M)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.
ORCID: 0000-0001-9994-9723

Philippa M Saunders (PM)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.
ORCID: 0000-0002-0813-7752

Zhangying Cai (Z)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.

James A Gray (JA)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.

Jacqueline M L Widjaja (JML)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.
ORCID: 0000-0002-4946-5584

Jie Lin (J)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.

Gabriella Pietra (G)

Department of Experimental Medicine (DiMES). University of Genoa, Genoa 16132, Italy.
Unità Operativa Complessa Immunologia, Ospedale Policlinico San Martino, Genoa 16132, Italy.
ORCID: 0000-0002-7080-531X

Maria Cristina Mingari (MC)

Department of Experimental Medicine (DiMES). University of Genoa, Genoa 16132, Italy.
Unità Operativa Complessa Immunologia, Ospedale Policlinico San Martino, Genoa 16132, Italy.
Center of Excellence for Biomedical Research, University of Genoa, Genoa 16132, Italy.

Lorenzo Moretta (L)

Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Pediatrico Bambino Gesù, 00165 Roma, Italy.

Jerome Samir (J)

School of Medical Sciences and The Kirby Institute, UNSW, Sydney, New South Wales, Australia.
ORCID: 0000-0001-6557-9373

Fabio Luciani (F)

School of Medical Sciences and The Kirby Institute, UNSW, Sydney, New South Wales, Australia.

Glen P Westall (GP)

Lung Transplant Service, The Alfred Hospital and Monash University Melbourne, Victoria 3000, Australia.

Karl J Malmberg (KJ)

KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway.
Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo 0310, Norway.
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, 14186 Stockholm, Sweden.
ORCID: 0000-0002-8718-9373

Katherine Kedzierska (K)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia.
ORCID: 0000-0001-6141-335X

Andrew G Brooks (AG)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Parkville, Victoria 3010, Australia. lcsull@unimelb.edu.au agbrooks@unimelb.edu.au.
ORCID: 0000-0002-4085-9683

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › Natural killer cell receptors regulate...
questionsmedicales.fr › Virus › Virus à ADN › Herpesviridae › Betaherpesvirinae › Cytomegalovirus › Natural killer cell receptors regulate...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ADN › Infections à Herpesviridae › Infections à cytomégalovirus › Natural killer cell receptors regulate...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes d'histocompatibilité de classe I › Natural killer cell receptors regulate...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Natural killer cell receptors regulate...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Cellules tueuses naturelles › Natural killer cell receptors regulate...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs aux antigènes › Récepteurs aux antigènes des cellules T › Natural killer cell receptors regulate...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs de cellules tueuses naturelles › Natural killer cell receptors regulate...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Natural killer cell receptors regulate...